<DOC>
	<DOC>NCT02378792</DOC>
	<brief_summary>Evaluate the long-term clinical effectiveness and safety of the PINS vagus nerve stimulator to patients with refractory epilepsy.</brief_summary>
	<brief_title>Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>1. Age 660. 2. Having tried at least two appropriate antiepileptic drugs (AEDs) tested to tolerance or to blood levels at upper end of the target range of which at least 2 have been tolerated at normal dose. 3. At least 1 seizure per month. 4. In good health except epilepsy. 5. With normal MMSE score 6. Patients or his(her) familyscould understand this method and sign the informed consent 7）Patients with good compliance and could complete postoperative followup. 1. Results of MRI remind epilepsy caused by intracranial spaceoccupying lesions. 2. The vagus nerve lesion and damage 3. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma，mental disease，pepticulcer，diabetes Type 1，bad health etc, and other surgical contraindication 4. Alcohol addiction, smoking, and sleeprelated breathing disorders</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>PINS VNS Refractory Epilepsy</keyword>
</DOC>